These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29498234)

  • 41. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa.
    Eaton JW; Johnson LF; Salomon JA; Bärnighausen T; Bendavid E; Bershteyn A; Bloom DE; Cambiano V; Fraser C; Hontelez JA; Humair S; Klein DJ; Long EF; Phillips AN; Pretorius C; Stover J; Wenger EA; Williams BG; Hallett TB
    PLoS Med; 2012; 9(7):e1001245. PubMed ID: 22802730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries.
    Sulzbach S; De S; Wang W
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i72-84. PubMed ID: 21729920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic and Policy Analytic Approaches to Inform the Acceleration of HIV Prevention in the United States: Future Directions for the Field.
    Martin EG; Rosenberg ES; Holtgrave DR
    AIDS Educ Prev; 2018 Jun; 30(3):199-207. PubMed ID: 29969310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV epidemic appraisals for assisting in the design of effective prevention programmes: shifting the paradigm back to basics.
    Mishra S; Sgaier SK; Thompson LH; Moses S; Ramesh BM; Alary M; Wilson D; Blanchard JF
    PLoS One; 2012; 7(3):e32324. PubMed ID: 22396756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimating the Cost-Effectiveness of HIV Prevention Programmes in Vietnam, 2006-2010: A Modelling Study.
    Pham QD; Wilson DP; Kerr CC; Shattock AJ; Do HM; Duong AT; Nguyen LT; Zhang L
    PLoS One; 2015; 10(7):e0133171. PubMed ID: 26196290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
    Bernard CL; Owens DK; Goldhaber-Fiebert JD; Brandeau ML
    PLoS Med; 2017 May; 14(5):e1002312. PubMed ID: 28542184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study.
    Williams BG; Gupta S; Wollmers M; Granich R
    Lancet Public Health; 2017 May; 2(5):e223-e230. PubMed ID: 29253488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Task-shifting alcohol interventions for HIV+ persons in Kenya: a cost-benefit analysis.
    Galárraga O; Gao B; Gakinya BN; Klein DA; Wamai RG; Sidle JE; Papas RK
    BMC Health Serv Res; 2017 Mar; 17(1):239. PubMed ID: 28351364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.
    Cremin I; Alsallaq R; Dybul M; Piot P; Garnett G; Hallett TB
    AIDS; 2013 Jan; 27(3):447-58. PubMed ID: 23296196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058.
    van de Vijver DAMC; Richter AK; Boucher CAB; Gunsenheimer-Bartmeyer B; Kollan C; Nichols BE; Spinner CD; Wasem J; Schewe K; Neumann A
    Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating the impact of reducing violence against female sex workers on HIV epidemics in Kenya and Ukraine: a policy modeling exercise.
    Decker MR; Wirtz AL; Pretorius C; Sherman SG; Sweat MD; Baral SD; Beyrer C; Kerrigan DL
    Am J Reprod Immunol; 2013 Feb; 69 Suppl 1():122-32. PubMed ID: 23387931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the promise of methadone Kenya's solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study.
    Rhodes T; Guise A; Ndimbii J; Strathdee S; Ngugi E; Platt L; Kurth A; Cleland C; Vickerman P
    BMJ Open; 2015 Mar; 5(3):e007198. PubMed ID: 25748417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya.
    Alsallaq RA; Buttolph J; Cleland CM; Hallett T; Inwani I; Agot K; Kurth AE
    PLoS One; 2017; 12(4):e0175447. PubMed ID: 28403211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis on funds application of community based organizations involved in HIV/AIDS response and government financial investment in China, 2014].
    Zhang G; Zhu YX; Wang P; Liu P; Li JF; Sha S; Yang WZ; Li H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):232-236. PubMed ID: 28260337
    [No Abstract]   [Full Text] [Related]  

  • 57. Public funding of HIV/AIDS prevention, treatment, and support in California.
    Leibowitz AA; Mendes AC; Desmond K
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):e11-6. PubMed ID: 21546846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of the US President's Emergency Plan for AIDS Relief's Funding With Prevention of Mother-to-Child Transmission of HIV in Kenya.
    Barnhart DA; Tsikhutsu I; Kirui D; Sawe F; Muli J; Sugut W; Abboud N; Birx D; Hamm T; Coakley P; Hickey PW; Wolfman V; Lee E; Spiegelman D
    JAMA Netw Open; 2019 Sep; 2(9):e1911318. PubMed ID: 31517966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reducing the spread of HIV infection in sub-Saharan Africa: some demographic and economic implications.
    Rowley JT; Anderson RM; Ng TW
    AIDS; 1990 Jan; 4(1):47-56. PubMed ID: 2317308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Programmes for the prevention of mother-to-child HIV infection transmission have made progress in Yunnan Province, China, from 2006 to 2015: a cost effective and cost-benefit evaluation.
    Wang X; Guo G; Zheng J; Lu L
    BMC Infect Dis; 2019 Jan; 19(1):64. PubMed ID: 30654744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.